{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-001042","form_type":"8-K","ticker":"AVXL","cik":"0001314052","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2026-08-11T21:00:32+00:00","discovered_at":"2026-08-11T21:02:00.334933+00:00","generated_at":"2026-08-11T21:02:25.792278+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Anavex files proxy for Sep 24 meeting, adds two independent directors amid PVG proxy fight","bullets":["2026 annual meeting set for Sep 24, 2026; record date Jul 31, 2026; PVG owns 0.35% of shares.","Board nominates Gautam Patel and Dr. Adrian Senderowicz as new independent directors; half of board refreshed.","Interim CEO Dr. Terrie Kellmeyer leading; blarcamesine advanced in Alzheimer's, Rett, Fragile X with FDA talks.","Anavex urges votes for six WHITE card nominees; cites PVG slate lacks FDA/drug development expertise.","Nasdaq delinquency notice for late Q1 10-Q received May 20, 2026; listing unaffected, compliance plan filed."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-001042","json":"https://secwatch.observer/filing/0001731122-26-001042.json","markdown":"https://secwatch.observer/filing/0001731122-26-001042.md","text":"https://secwatch.observer/filing/0001731122-26-001042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226001042/0001731122-26-001042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226001042/e7842_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-11T21:02:25.792278+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}